RxDoctor Payments Data

Seth Ruggles, DO

Family Medicine · Norwalk, OHNPI 1255404786

Payments from drug & device makers

$803in general payments, 2019–2025

Across 46 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$456
  • Boehringer Ingelheim$153
  • Lilly USA, LLC$51
  • Novo Nordisk$48
  • E.r. Squibb & Sons, L.L.C.$35
  • Merck$27
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$803 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,652
Medicare patients
253
Services billed
1,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate70$73,200
TrulicityDulaglutide55$67,544
OzempicSemaglutide52$62,641
EliquisApixaban60$57,650
JardianceEmpagliflozin42$48,977
CreonLipase/Protease/Amylase20$41,133
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$28,944
XareltoRivaroxaban19$22,389
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$16,510
TradjentaLinagliptin11$14,056
SymbicortBudesonide/Formoterol Fumarate17$7,356
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$5,815
PaxlovidNirmatrelvir/Ritonavir14$5,611
Breo ElliptaFluticasone/Vilanterol14$5,245
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$5,198

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$27$73,20070 claims
Lilly USA, LLCTrulicity$51$67,54455 claims
Boehringer IngelheimJardiance, Tradjenta$153$63,03353 claims
Novo NordiskOzempic$48$62,64152 claims
AbbVieCreon, Armour Thyroid$456$43,43840 claims
AstraZenecaSymbicort$13$7,35617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Norwalk

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →